Search research articles
Contact Us
Filters
Showing results (31-40 of 76) with videos related to
Page
of 8
Sort By:
Annals of Hematology
|
October 10, 2021
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study
Oren Pasvolsky, Shai Shimony, Ron Ram, et al.
Haematologica
|
December 1, 2022
Investigational venetoclax combination therapy in acute myeloid leukemia - a systematic review and meta-analysis
Shai Shimony, Alon Rozental, Jan P Bewersdorf, et al.
Hematological Oncology
|
November 2, 2019
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study
Shai Shimony, Netanel Horowitz, Elena Ribakovsky, et al.
Leukemia
|
March 28, 2024
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients
Shai Shimony, Jacqueline S Garcia, Julia Keating, et al.
Annals of Hematology
|
June 19, 2023
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort study
Tamar Berger, Tzippy Shochat, Shlomzion Aumann, et al.
Leukemia & Lymphoma
|
April 21, 2021
Post-transplantation maintenance with sorafenib or midostaurin for FLT3 positive AML patients - a multicenter retrospective observational study
Shai Shimony, Moshe Yeshurun, Ofir Wolach, et al.
Biomedicines
|
July 27, 2024
Chronic Lymphocytic Leukemia (CLL)-Derived Extracellular Vesicles Educate Endothelial Cells to Become IL-6-Producing, CLL-Supportive Cells
Orit Uziel, Lian Lipshtein, Zinab Sarsor, et al.
Annals of Hematology
|
June 22, 2022
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis
Ofir Wolach, Avraham Frisch, Liat Shargian, et al.
Annals of Hematology
|
November 10, 2023
Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study
Odil Giladi, Gianmarco Bagnato, Marianna Gentilini, et al.
Annals of Hematology
|
June 23, 2022
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis
Shai Shimony, Jonathan Canaani, Eitan Kugler, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 76) with videos related to
Sort By:
Page
of 8
Annals of Hematology
|
October 10, 2021
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study
Oren Pasvolsky, Shai Shimony, Ron Ram, et al.
Haematologica
|
December 1, 2022
Investigational venetoclax combination therapy in acute myeloid leukemia - a systematic review and meta-analysis
Shai Shimony, Alon Rozental, Jan P Bewersdorf, et al.
Hematological Oncology
|
November 2, 2019
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study
Shai Shimony, Netanel Horowitz, Elena Ribakovsky, et al.
Leukemia
|
March 28, 2024
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients
Shai Shimony, Jacqueline S Garcia, Julia Keating, et al.
Annals of Hematology
|
June 19, 2023
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort study
Tamar Berger, Tzippy Shochat, Shlomzion Aumann, et al.
Leukemia & Lymphoma
|
April 21, 2021
Post-transplantation maintenance with sorafenib or midostaurin for FLT3 positive AML patients - a multicenter retrospective observational study
Shai Shimony, Moshe Yeshurun, Ofir Wolach, et al.
Biomedicines
|
July 27, 2024
Chronic Lymphocytic Leukemia (CLL)-Derived Extracellular Vesicles Educate Endothelial Cells to Become IL-6-Producing, CLL-Supportive Cells
Orit Uziel, Lian Lipshtein, Zinab Sarsor, et al.
Annals of Hematology
|
June 22, 2022
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis
Ofir Wolach, Avraham Frisch, Liat Shargian, et al.
Annals of Hematology
|
November 10, 2023
Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study
Odil Giladi, Gianmarco Bagnato, Marianna Gentilini, et al.
Annals of Hematology
|
June 23, 2022
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis
Shai Shimony, Jonathan Canaani, Eitan Kugler, et al.
Page
of 8